http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2716144-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4b227d9147ef9486fd62ec730d426f2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-06 |
| filingDate | 2019-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e74ee56ae5d4798ba1e5a99eec60da6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb1ef32126aa909a07664df4999f4215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc8c072ebca00375cb75151b9e23bcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebe2c2b78fd67f1bcf1cc830ddadeb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b7f20acd3a5ab14c8f51bf46784b006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a81d4e6ce09edc78545a3a5dde8392 |
| publicationDate | 2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2716144-C1 |
| titleOfInvention | Method for conservative treatment of postoperative enteroparesis in newborns |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to neonatology and pediatric surgery, and can be used for conservative treatment of postoperative enteroparesis in newborns. For this purpose, a glucose-salt solution of the following composition is introduced into the newborn with enteroparesis, in the absence of stool and stagnation in the stomach, enterally through the nipple or through a gastric tube in the mode of continuous infusion or bolus every 3 hours 8 times a day: 3.5 ml of 4 % potassium chloride solution; 1.5 ml of 40 % glucose solution; 1.5 ml of 10 % calcium gluconate solution; 1 ml of 25 % magnesium sulphate solution and up to 100 ml of distilled water. Initial volume is 5 ml per one feeding. If adequately digested, the volume of the solution is increased to 10–15 ml. Control of digestion is carried out by availability and volume of stool, absence of signs of stagnation in stomach. After adequate assimilation of the glucose-saline solution is achieved, introduction of the actual product for enteral nutrition, for example native expressed breast milk or adapted mixture, wherein the glucose-salt solution is continued to be given in the gaps between the feedings until the independent stool appearance, after which the solution is withdrawn.EFFECT: method enables recovery of motor-evacuation intestine function with no side effects.1 cl, 3 ex |
| priorityDate | 2019-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.